[1] Schneditz D,Ribitsch W,Schilcher G et al. Concordance of absolute and relative plasma volume changes and stability of F cells in routine hemodialysis. Hemodial Int,2016,20(1):120-128. [2] 李晨,游绍莉,辛绍杰. HBV相关ACLF前期概念及诊疗新进展. 实用肝脏病杂志,2015,18(1):105-108. [3] Woodhouse CA,Patel VC,Singanayagam A,et al.The gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. Aliment Pharmacol Ther,2018,47(2):192-202. [4] Yokoi T,Oda S,Shiga H,et al.Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failure. Transfus Apher Sci,2009,40(1):61-70. [5] Galach M,Antosiewicz S,Baczynski D,et al.Sequential peritoneal equilibration test:a new method for assessment and modelling of peritoneal transport. Nephrol Dial Transplant,2013,28(2):447-454. [6] Botelho C,Rodrigues A,Oliveira JC,et al.Peritoneal phosphate removal varies by peritoneal dialysis regimen:an underestimated parameter of phosphate control. J Nephrol,2013,26(1):183-190. [7] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版). 实用肝脏病杂志,2013,16(3):210-216. [8] Mariano F,Leporati M,Carignano P,et al.Efficient removal of colistin A and B in critically ill patients undergoing CVVHDF and sorbent technologies. J Nephrol,2015,28(5):623-631. [9] Ichai P,Samuel D.Dynamic outcome prediction for paracetamol-related acute liver failure. Lancet Gastroenterol Hepatol,2016,1(3):177-178. [10] Li M,Sun J,Li J,et al.Clinical observation on the treatment of acute liver failure by combined non-biological artificial liver. Exp Ther Med,2016,12(6):3873-3876. [11] Raoufinia R,Mota A,Keyhanvar N,et al.Overview of albumin and its purification methods. Adv Pharm Bull,2016,6(4):495-507. [12] 邓勤智,夏邦恩,王世和,等. 土茯苓组方在乙型肝炎病毒ACLF中的应用及疗效分析.中华中医药杂志,2015,30(3):739-742. [13] Karki P,Malik S,Mallick B,et al.Massive hemolysis causing renal failure in acute hepatitis E infection. J Clin Transl Hepatol,2016,4(4):345-347. [14] 张绪清,毛青. 急性肝衰竭早期预警及预后评估. 实用肝脏病杂志,2013,16(1):14-16. [15] Clària J,Arroyo V,Moreau R.The acute-on-chronic liver failure syndrome,or when the innate immune system goes astray. J Immunol,2016,197(10):3755-3761. [16] Kim SH,Song GW,Hwang S,et al.Feasibility of ABO-incompatible adult living donor liver transplantation for acute-on-chronic liver failure. Hepatobiliary Pancreat Dis Int,2017,16(6):662-664. [17] Pannu AK,Bhalla A,Rao C,et al.Delta model for end-stage liver disease and delta clinical prognostic indicator as predictors of mortality in patients with viral acute liver failure. Int J Crit Illn Inj Sci,2017,7(4):252-255. [18] André P,Villain F.Free radical scavenging properties of mannitol and its role as a constituent of hyaluronic acid fillers:a literature review. Int J Cosmet Sci,2017,39(4):355-360. [19] Cheng Y,Freeden C,Zhang Y,et al.Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment. Biopharm Drug Dispos,2016,37(5):276-86. [20] Bhatnagar G,Sharma S,Kumar A,et al.Reduced glutathione in hepatitis E infection and pregnancy outcome. J Obstet Gynaecol Res,2016,42(7):789-795. [21] Seyam E,Hasan M,Khalifa EM,et al.Evaluation of tumor necrosis factor alpha serum level in obese and lean women with clomiphene citrate-resistant polycystic ovary disease. Gynecol Endocrinol,2017,33(11):892-898. |